✦ LIBER ✦

Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience

✍ Scribed by Ian C Lawrance; Graham L Radford-Smith; Peter A Bampton; Jane M Andrews; Pok-Kern Tan; Anthony Croft; Richard B Gearry; Timothy H J Florin

Book ID: 108953823
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 131 KB
Volume: 25
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2010.06407.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased hospitalizations in elderly wi

Increased hospitalizations in elderly with inflammatory bowel disease on anti-tumor necrosis factor therapy but not increased infections: A community practice experience

✍ Shen, Huafeng; Lipka, Seth; Katz, Seymour 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 132 KB

Advanced Age Is an Independent Risk Fact

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

✍ Cottone, Mario; Kohn, Anna; Daperno, Marco; Armuzzi, Alessandro; Guidi, Luisa; D 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Mo1703 Incidence of Selected Adverse Eve

Mo1703 Incidence of Selected Adverse Events (AES) in Inflammatory Bowel Disease (IBD) Patients With and Without Exposure to Anti-Tumor Necrosis Factor Alpha (Anti-TNFa) Therapy

✍ McAuliffe, Megan E.; Leach, Tim; Fox, Irving; Lanes, Stephan; Faich, Gerald; Por 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Tu1314 The Safety and Efficacy of Anti-T

Tu1314 The Safety and Efficacy of Anti-Tumor Necrosis Factor-Alpha Therapy for Inflammatory Bowel Disease in Patients Post-Liver Transplantation: A Case Series

✍ Sandhu, Amindeep S.; AlAmeel, Turki; Dale, Cheryl; Levstik, Mark; Chande, Nilesh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Differences in the incidence of flares o

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents

✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co

Su1161 Risk of Solid Cancers With Tumor

Su1161 Risk of Solid Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

✍ Stobaugh, Derrick J.; Deepak, Parakkal; Ehrenpreis, Eli D. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 297 KB